CDTX - Cidara Therapeutics GAAP EPS of $0.03 beats by $0.07 revenue of $25.99M beats by $7.31M May, 11 2023 05:29 PM Cidara Therapeutics Inc. 2023-05-11 17:29:33 ET Cidara Therapeutics press release ( NASDAQ: CDTX ): Q1 GAAP EPS of $0.03 beats by $0.07 . Revenue of $25.99M (+265.5% Y/Y) beats by $7.31M . For further details see: Cidara Therapeutics GAAP EPS of $0.03 beats by $0.07, revenue of $25.99M beats by $7.31M